• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

美国顶尖学术医学中心的代写现象。

Ghostwriting at elite academic medical centers in the United States.

机构信息

School of Social Work, College of Public Programs, Arizona State University, Phoenix, Arizona, USA.

出版信息

PLoS Med. 2010 Feb 2;7(2):e1000230. doi: 10.1371/journal.pmed.1000230.

DOI:10.1371/journal.pmed.1000230
PMID:20126384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2814828/
Abstract

Jeffrey Lacasse and Jonathan Leo assess ghostwriting policies at 50 academic medical centers in the United States and find that only 10 explicitly prohibit ghostwriting.

摘要

杰弗里·拉卡塞和乔纳森·利奥评估了美国 50 家学术医学中心的代笔政策，发现只有 10 家明确禁止代笔。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf4/2814828/7c5c28674ff1/pmed.1000230.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf4/2814828/7c5c28674ff1/pmed.1000230.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf4/2814828/7c5c28674ff1/pmed.1000230.g001.jpg

相似文献

1
Ghostwriting at elite academic medical centers in the United States.美国顶尖学术医学中心的代写现象。
PLoS Med. 2010 Feb 2;7(2):e1000230. doi: 10.1371/journal.pmed.1000230.
2
Profits and plagiarism: the case of medical ghostwriting.利润与剽窃：医学代写的案例。
Bioethics. 2010 Jul;24(6):267-72. doi: 10.1111/j.1467-8519.2008.00705.x. Epub 2009 Feb 16.
3
Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.利益冲突还是富有成效的合作？制药行业与学术界的关系及其对头痛医学的影响。
Headache. 2006 Jul-Aug;46(7):1181-5. doi: 10.1111/j.1526-4610.2006.00508.x.
4
NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.神经中枢：随着许多学术医疗中心进行自查，美国监察长办公室就国立卫生研究院对利益冲突监督不力发出警告。
Ann Neurol. 2010 Mar;67(3):A7-A10. doi: 10.1002/ana.22026.
5
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.与行业相关的科学出版物中的利益冲突、作者身份及信息披露：侵权律师与医学期刊的编辑监督
Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811.
6
New developments in managing physician-industry relationships.管理医生与产业界关系的新进展。
JAMA. 2008 Sep 3;300(9):1067-9. doi: 10.1001/jama.300.9.1067.
7
[Publication ethics: regulation of financial conflicts of interests in medical journals].[出版伦理：医学期刊中经济利益冲突的规范]
Lege Artis Med. 2011 Jan;21(1):65-71.
8
Managing conflicts of interest: who, and how?管理利益冲突：何人，如何管理？
Med J Aust. 2012 Apr 16;196(7):427. doi: 10.5694/mja12.c0416.
9
Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?涉及行业与医学期刊的双向利益冲突：谁将捍卫诚信？
Mayo Clin Proc. 2009 Sep;84(9):771-5. doi: 10.4065/84.9.771.
10
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.引发利益冲突的医疗行业行为：针对学术医疗中心的一项政策提案
JAMA. 2006 Jan 25;295(4):429-33. doi: 10.1001/jama.295.4.429.

引用本文的文献

1
Publication of observational studies making claims of causation over time.随着时间推移，发表声称存在因果关系的观察性研究。
Contemp Clin Trials Commun. 2024 Jun 17;40:101327. doi: 10.1016/j.conctc.2024.101327. eCollection 2024 Aug.
2
Describing the Attributional Nature of Academic Dishonesty.描述学术不诚实行为的归因本质。
Med Sci Educ. 2019 Feb 19;29(2):577-581. doi: 10.1007/s40670-019-00710-8. eCollection 2019 Jun.
3
Authorship Policies at U.S. Doctoral Universities: A Review and Recommendations for Future Policies.

本文引用的文献

1
Ethical considerations of publication planning in the pharmaceutical industry.制药行业出版计划的伦理考量
Open Med. 2008;2(4):e121-4. Epub 2008 Dec 23.
2
Ghostwriting: the dirty little secret of medical publishing that just got bigger.代写论文：医学出版界的肮脏小秘密，现在变得更大了。
PLoS Med. 2009 Sep;6(9):e1000156. doi: 10.1371/journal.pmed.1000156. Epub 2009 Sep 8.
3
Ghosts in the machine: publication planning in the medical sciences.机器中的幽灵：医学科学中的出版规划
美国博士学位授予大学的学术作者身份政策：回顾与未来政策建议。
Sci Eng Ethics. 2020 Dec;26(6):3393-3413. doi: 10.1007/s11948-020-00273-7. Epub 2020 Nov 19.
4
Perish or Publish Dilemma: Challenges to Responsible Authorship.生死抉择：负责任的作者身份面临的挑战。
Medicina (Kaunas). 2020 Mar 12;56(3):123. doi: 10.3390/medicina56030123.
5
Authors' awareness of concepts in the authorship of scientific publications: Viewpoints of the dental faculty in India.作者对科学出版物署名概念的认识：印度牙科教师的观点。
J Oral Biol Craniofac Res. 2018 Sep-Dec;8(3):151-153. doi: 10.1016/j.jobcr.2016.05.001. Epub 2016 May 20.
6
How basic scientists help the pharmaceutical industry market drugs.基础科学家如何帮助制药行业推广药物。
PLoS Biol. 2013 Nov;11(11):e1001716. doi: 10.1371/journal.pbio.1001716. Epub 2013 Nov 19.
7
Ethics of using language editing services in an era of digital communication and heavily multi-authored papers.数字通信时代及多作者论文盛行背景下使用语言编辑服务的伦理问题。
Sci Eng Ethics. 2014 Jun;20(2):363-77. doi: 10.1007/s11948-013-9451-6. Epub 2013 May 21.
8
Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses.对未披露的企业代笔情况（“捉刀代笔”）的了解会降低对抗抑郁药研究可信度的认知：一项针对经验丰富护士的随机 vignette 研究 。
BMC Res Notes. 2012 Sep 5;5:490. doi: 10.1186/1756-0500-5-490.
9
A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persists.DSM-IV 和 DSM-5 专家组委员与行业间财务关联的比较：一个有害问题仍然存在。
PLoS Med. 2012;9(3):e1001190. doi: 10.1371/journal.pmed.1001190. Epub 2012 Mar 13.
10
Authorship issues.作者身份问题。
Lung India. 2012 Jan;29(1):76-80. doi: 10.4103/0970-2113.92371.
Soc Stud Sci. 2009 Apr;39(2):171-98. doi: 10.1177/0306312708101047.
4
Publication ethics and the ghost management of medical publication.出版伦理与医学出版的幽灵管理。
Bioethics. 2010 Jul;24(6):273-83. doi: 10.1111/j.1467-8519.2008.01702.x. Epub 2009 Feb 16.
5
What should be done to tackle ghostwriting in the medical literature?应该采取什么措施来应对医学文献中的代笔问题？
PLoS Med. 2009 Feb 3;6(2):e23. doi: 10.1371/journal.pmed.1000023.
6
Industry-sponsored ghostwriting in clinical trial reporting: a case study.临床试验报告中行业资助的代笔行为：一项案例研究。
Account Res. 2008 Jul-Sep;15(3):152-67. doi: 10.1080/08989620802194384.
7
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.与罗非昔布相关出版物中的客座作者身份和代笔行为：以罗非昔布诉讼中的行业文件为例
JAMA. 2008 Apr 16;299(15):1800-12. doi: 10.1001/jama.299.15.1800.
8
Ghost marketing: pharmaceutical companies and ghostwritten journal articles.幽灵营销：制药公司与代笔期刊文章
Perspect Biol Med. 2007 Winter;50(1):18-31. doi: 10.1353/pbm.2007.0009.
9
Narrative review: the promotion of gabapentin: an analysis of internal industry documents.叙述性综述：加巴喷丁的推广：对行业内部文件的分析
Ann Intern Med. 2006 Aug 15;145(4):284-93. doi: 10.7326/0003-4819-145-4-200608150-00008.
10
On the origin of great ideas: science in the age of big pharma.论伟大思想的起源：大制药时代的科学
Hastings Cent Rep. 2005 Nov-Dec;35(6):17-9.